These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 24344422)
21. Modelling the Medication Management System for Resource Limited Settings: A Formal Representation of the Prescribing and Dispensing Phases. Ogallo W; Kanter AS Stud Health Technol Inform; 2015; 216():1106. PubMed ID: 26262405 [TBL] [Abstract][Full Text] [Related]
22. An integrated drug prescription and distribution system: challenges and opportunities. Lanssiers R; Everaert E; De Win M; Van De Velde R; De Clercq H Stud Health Technol Inform; 2002; 93():69-74. PubMed ID: 15058416 [TBL] [Abstract][Full Text] [Related]
23. The role of security in the prevention, detection and response to drug diversion by healthcare personnel. New K J Healthc Prot Manage; 2016 Oct; 32(2):33-38. PubMed ID: 29638276 [TBL] [Abstract][Full Text] [Related]
24. [Equity in Health: all we need to know]. Costa G Epidemiol Prev; 2014; 38(6):352-4. PubMed ID: 25651764 [No Abstract] [Full Text] [Related]
25. Push technology in the pharmacy. Clinical decision support helps the pharmacy department of a South Carolina medical center automate monitoring of medication effectiveness. Amsden D Health Manag Technol; 2003 Jan; 24(1):28-31. PubMed ID: 12564140 [No Abstract] [Full Text] [Related]
26. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran. Cheraghali AM; Nikfar S; Behmanesh Y; Rahimi V; Habibipour F; Tirdad R; Asadi A; Bahrami A East Mediterr Health J; 2004 May; 10(3):406-15. PubMed ID: 16212218 [TBL] [Abstract][Full Text] [Related]
27. Equity analysis of resource distribution for the Popular Pharmacy Program. Silva MELE; Almeida ATC; Araújo Júnior IT Rev Saude Publica; 2019 May; 53():50. PubMed ID: 31116239 [TBL] [Abstract][Full Text] [Related]
28. Pharmaceutical availability across levels of care: evidence from facility surveys in Ghana, Kenya, and Uganda. Masters SH; Burstein R; DeCenso B; Moore K; Haakenstad A; Ikilezi G; Achan J; Osei I; Garshong B; Kisia C; Njuguna P; Babigumira J; Kumar S; Hanlon M; Gakidou E PLoS One; 2014; 9(12):e114762. PubMed ID: 25500832 [TBL] [Abstract][Full Text] [Related]
29. World pharmaceutical developments. Bale H World Hosp Health Serv; 2002; 38(2):1. PubMed ID: 12402745 [No Abstract] [Full Text] [Related]
30. Survey of state requirements for unit-of-use packaging. Szeinbach SL; Baron M; Guschke T; Torkilson EA Am J Health Syst Pharm; 2003 Sep; 60(18):1863-6. PubMed ID: 14521038 [No Abstract] [Full Text] [Related]
31. Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines. Balhara YP J Opioid Manag; 2013; 9(4):237. PubMed ID: 24380101 [No Abstract] [Full Text] [Related]
32. Access to essential drugs, human rights and global justice. Shalev C Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024 [No Abstract] [Full Text] [Related]
33. Access to Antihypertensive Drugs in China. Bai G; Bennet C; Wang J; Anderson GF Circulation; 2018 Oct; 138(17):1777-1779. PubMed ID: 30354658 [No Abstract] [Full Text] [Related]
34. Are essential medicines in Malaysia accessible, affordable and available? Saleh K; Ibrahim MI Pharm World Sci; 2005 Dec; 27(6):442-6. PubMed ID: 16341951 [TBL] [Abstract][Full Text] [Related]
35. Essential Medicines in the United States--Why Access Is Diminishing. Alpern JD; Song J; Stauffer WM N Engl J Med; 2016 May; 374(20):1904-7. PubMed ID: 27192669 [No Abstract] [Full Text] [Related]
37. User Preferences for Improving the Estonian National e-Prescription Service. Parv L; Monkman H; Laus R Stud Health Technol Inform; 2015; 218():15-19. PubMed ID: 26262520 [TBL] [Abstract][Full Text] [Related]
38. More tips for managing prescription refills. Bley DE Fam Pract Manag; 2012; 19(1):5. PubMed ID: 22335370 [No Abstract] [Full Text] [Related]